Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 11
Submit an article Journal homepage
329
Views
11
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Safety and feasibility of lower antithrombin replacement targets in adult patients with hematological malignancies receiving asparaginase therapy*

Jason N. BarretoDepartment of Pharmacy Services, Mayo Clinic, Rochester, MN, USA; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-2146-5766View further author information
ORCID Icon,
Kristen B. McCulloughDepartment of Pharmacy Services, Mayo Clinic, Rochester, MN, USA; View further author information
,
Candy S. PeskeyDepartment of Pharmacy Services, Mayo Clinic, Rochester, MN, USA; View further author information
,
Ross A. DierkhisingDivision of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA; View further author information
,
Kristin C. MaraDivision of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA; View further author information
,
Michelle A. ElliottDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USAView further author information
,
Dennis A. GastineauDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USAORCID Iconhttp://orcid.org/0000-0003-2250-9812View further author information
ORCID Icon,
Aref Al-KaliDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USAORCID Iconhttp://orcid.org/0000-0002-0824-3715View further author information
ORCID Icon,
Naseema GangatDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USAView further author information
,
Louis LetendreDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USAView further author information
,
William J. HoganDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USAORCID Iconhttp://orcid.org/0000-0002-5841-4105View further author information
ORCID Icon,
Mark R. LitzowDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USAORCID Iconhttp://orcid.org/0000-0002-9816-6302View further author information
ORCID Icon &
Mrinal M. PatnaikDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USAORCID Iconhttp://orcid.org/0000-0001-6998-662XView further author information
ORCID Icon show all
Pages 2588-2597 | Received 02 Feb 2017, Accepted 19 Mar 2017, Published online: 09 May 2017

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

YeeAnn Chen, Kaitlyn Buhlinger, Anthony J. Perissinotti, Allison J. Schepers, Lydia Benitez, Jessica Auten, Sheh-Li Chen, Dale L. Bixby, Patrick W. Burke, Kristen M. Pettit & Bernard L. Marini. (2022) Solving coagulation conundrums: comparing prophylaxis strategies in adult patients receiving PEG-asparaginase. Leukemia & Lymphoma 63:11, pages 2663-2670.
Read now
Craig W. Freyer, Alison Carulli, Alex Ganetsky, Mitchell E. Hughes, Tracy M. Krause, Colleen Timlin, Noelle V. Frey, Saar I. Gill, Elizabeth O. Hexner, Alison W. Loren, James K. Mangan, Mary Ellen Martin, Shannon R. McCurdy, Alexander E. Perl, Keith Pratz, David L. Porter & Selina M. Luger. (2020) Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation. Leukemia & Lymphoma 61:9, pages 2200-2207.
Read now
Jason Chen, Dat Ngo, Ibrahim Aldoss, Sepideh Shayani, Ni-Chun Tsai & Vinod Pullarkat. (2019) Antithrombin supplementation did not impact the incidence of pegylated asparaginase-induced venous thromboembolism in adults with acute lymphoblastic leukemia. Leukemia & Lymphoma 60:5, pages 1187-1192.
Read now

Articles from other publishers (8)

J. R. Gonzalez-Porras, J. Mateo, V. Gonzalez-Calle, P. Marco, V. Garcia-Gutierrez, J. C. Reverter & R. Lecumberri. (2021) Prevention of venous thromboembolism in hematologic neoplasms: an expert consensus from SEHH–SETH. Clinical and Translational Oncology 24:5, pages 770-783.
Crossref
Cecilie U Rank, Line Stensig Lynggaard, Bodil Als-Nielsen, Wendy Stock, Nina Toft, Ove Juul Nielsen, Thomas Leth Frandsen, Ruta Tuckuviene & Kjeld Schmiegelow. (2020) Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia. Cochrane Database of Systematic Reviews 2020:10.
Crossref
Gemlyn George, Alexandra Rezazadeh, Felicia Zook, Nicole Pearl, Cole McCoy, Karen Carlson, Lyndsey Runaas, Sameem Abedin, Guru Subramanian Guru Murthy, Laura C. Michaelis, Ehab Atallah & Lisa Baumann-Kreuziger. (2020) Reducing venous thrombosis with antithrombin supplementation in patients undergoing treatment for ALL with Peg-asparaginase—A real world study. Leukemia Research 94, pages 106368.
Crossref
J. Fulcher & M. Carrier. (2020) Thromboembolism prophylaxis during L-asparaginase therapy in acute lymphoblastic leukemia – time to reconsider current approaches?. Thrombosis Research 188, pages 100-102.
Crossref
Jeffrey I. Zwicker, Tzu‐Fei Wang, Daniel J. DeAngelo, Mandy N. Lauw, Jean M. Connors, Anna Falanga, Malgorzata McMasters & Marc Carrier. (2020) The prevention and management of asparaginase‐related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH. Journal of Thrombosis and Haemostasis 18:2, pages 278-284.
Crossref
Najeebah A Bade, Crystal Lu, Ciera L Patzke, Maria R Baer, Vu H Duong, Jennie Y Law, Seung T Lee, Edward A Sausville, Ann B Zimrin, Alison P Duffy, Justin Lawson & Ashkan Emadi. (2019) Optimizing pegylated asparaginase use: An institutional guideline for dosing, monitoring, and management. Journal of Oncology Pharmacy Practice 26:1, pages 74-92.
Crossref
Jennifer Young, Jaclyn Sawyer, Meredith Jenkins, Maureen O'Brien, Lori Luchtman‐Jones & Erin H. Breese. (2019) Capped antithrombin III dosing is cost effective in the management of asparaginase‐associated thrombosis. Pediatric Blood & Cancer 66:6, pages e27719.
Crossref
. (2017) Asparaginase/pegaspargase. Reactions Weekly 1669:1, pages 35-35.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.